Phibro Animal Health (PAHC) Depreciation and Depletion (2013 - 2026)
Phibro Animal Health's (PAHC) quarterly Depreciation and Depletion came in at $10.7 million in Q1 2026, down 1.57% year-on-year from $10.9 million in Q1 2025, and down 4.04% quarter-over-quarter from $11.2 million in Q4 2025.
Phibro Animal Health (PAHC) Depreciation and Depletion (2013 - 2026) Analysis & Trends
Phibro Animal Health's Depreciation and Depletion history runs 14 years deep, the most recent figure standing at $10.7 million for Q1 2026.
- On a quarterly basis, Depreciation and Depletion fell 1.57% year-over-year to $10.7 million in Q1 2026; TTM through Mar 2026 was $43.7 million, a 28.92% increase from a year earlier, with the FY2025 full-year figure at $37.8 million, up 42.41% from the prior year.
- Depreciation and Depletion slipped to $10.7 million in Q1 2026 per PAHC's latest filing, from $11.2 million in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $11.2 million in Q4 2025 and bottomed at $6.0 million in Q2 2022.
- The 5-year median for Depreciation and Depletion is $6.7 million (2024), against an average of $7.9 million.
- Across the five-year window, Depreciation and Depletion retreated 2.37% in 2023 and jumped 64.95% in 2025, its largest moves.
- Year by year, Depreciation and Depletion stood at $6.1 million in 2022, then grew by 6.24% to $6.4 million in 2023, then jumped by 46.17% to $9.4 million in 2024, then increased by 18.8% to $11.2 million in 2025, then retreated by 4.04% to $10.7 million in 2026.
- Per Business Quant, the three latest PAHC Depreciation and Depletion figures stand at $10.7 million (Q1 2026), $11.2 million (Q4 2025), and $11.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 36.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 28.00 Mn |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | 10.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.73 Mn |
| Mar 31, 2026 | 10.73 Mn |
| Dec 31, 2025 | 11.18 Mn |
| Dec 31, 2025 | 11.18 Mn |
| Sep 30, 2025 | 11.12 Mn |
| Sep 30, 2025 | 11.12 Mn |
| Jun 30, 2025 | 10.71 Mn |
| Jun 30, 2025 | 10.71 Mn |
| Mar 31, 2025 | 10.90 Mn |
| Mar 31, 2025 | 10.90 Mn |
| Dec 31, 2024 | 9.41 Mn |
| Dec 31, 2024 | 9.41 Mn |
| Sep 30, 2024 | 6.74 Mn |
| Sep 30, 2024 | 6.74 Mn |
| Jun 30, 2024 | 6.88 Mn |
| Jun 30, 2024 | 6.88 Mn |
| Mar 31, 2024 | 6.77 Mn |
| Mar 31, 2024 | 6.77 Mn |
| Dec 31, 2023 | 6.44 Mn |
| Dec 31, 2023 | 6.44 Mn |